Patient Guide: A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 11 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07117487
Status: 🟢 Enrolling Now
Condition: Respiratory Syncytial Virus
Phase: PHASE3

Where You Can Participate

This study is available at 11 locations across the country.

Top locations include:
  • • Denver, Colorado
  • • Hialeah, Florida
  • • Savannah, Georgia
  • • And 8 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of mRNA-1345 Following a Primary Dose of a Licensed Protein Subunit Respiratory Syncytial Virus (RSV) Vaccine in Adult Participants ≥60 Years of Age - Join Clinical Trial NCTNCT07117487

How to Join This Clinical Trial - NCTNCT07117487

Learn how to participate in this PHASE3 trial studying an investigational therapy for Respiratory Syncytial Virus. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Respiratory Syncytial Virus. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Respiratory Syncytial Virus
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07117487 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 11 locations. Find a study site near you:

Clinical Research Site

Denver, Colorado 80110 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Hialeah, Florida 33012 - United States

Status: RECRUITING

Clinical Research Site

Savannah, Georgia 31406 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Valparaiso, Indiana 46383 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Covington, Louisiana 70433 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Rockville, Maryland 20854 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Lincoln, Nebraska 68510 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Medford, Oregon 97504 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Austin, Texas 78759 - United States

Status: NOT_YET_RECRUITING

Clinical Research Site

Hampton, Virginia 23666 - United States

Status: NOT_YET_RECRUITING

And 1 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Respiratory Syncytial Virus:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships